The Latest

Whether you're a patient, clinician, retailer or researcher, come with us as we work to bring quality, accessible cannabis care (and data) to all.

Featured

News

EO Care, Inc. Statement on Cannabinoid Policy Announcements

December 18, 2025

EO Team

The Administration’s decision to move to reclassify cannabis from Schedule I to Schedule III is a watershed moment for adult Americans who currently or might benefit from the responsible use of cannabinoids, especially oncology patients and older adults. It’s a long overdue step that will reduce stigma, open doors for essential research and product development, and increase access to care for patients.

News

EO Data & Methodology: November 2025 Update

At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from real people using cannabis to manage symptoms such as pain, sleep disturbance, anxiety, and nausea/vomiting, under the guidance of our clinical protocols.

News

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Meaningful improvements were reported by patients after one (1) week and sustained through four (4) weeks of guided cannabinoid care, particularly among people over 50 and cancer patients. Patients also reported low rates of use-limiting side effects with further reductions after receiving updated recommended product and/or dosing guidance via EO Care’s digital care platform.

News

Gaps in Guidance

Last week, you took an edible to help manage your anxiety after a long work day. The cannabis provided some relief, but since then you haven’t been able to recreate that result. Starting your cannabis journey is daunting, and it can be hard to know where to go for guidance.

Research

CBD & Gastrointestinal Pain

Cannabidiol (CBD) is a component of the plant cannabis with great potential for medical applications because of its proven anti-inflammatory, anti-tumoral, analgesic (pain-relieving), and anxiolytic (anxiety-relieving) properties and its lack of psychological side effects.

News

Cannabinoids & Pain Control

Proponents of cannabis use in a medical context have often suggested that it is a superior substitute of opioid for chronic pain management. Cannabis owes its analgesic properties to components called cannabinoids, with the two most prominent being cannabidiol (CBD) and tetrahydrocannabinol (THC). Both compounds have similar potential for treating chronic pain, however, while THC is addictive, CBD is not and therefore is of special clinical interest.

News

Cannabis & Sleeplessness

If you are having trouble getting a good night’s sleep these days, you’re not alone. Up to 70 million people are affected by sleep disorders, according to data from the National Institutes of Health, and consumers are spending $70 billion a year on sleep aids, 65% of which goes to medications.

Research

CB2 as a Regulator of Anxiety & Potential Target for PTSD Drugs

Researchers recently identified a signaling pathway in the endocannabinoid system that regulates long-lasting anxiety, a central symptom of post-traumatic stress disorder (PTSD). In particular, CB2 - one of the two main endocannabinoid receptors - mediates the response: its activation appears to have an anxiolytic (anxiety reducing) effect while its inhibition an anxiogenic (anxiety inducing) one.

News

The Pros & Cons of Vaporization

Researchers have recently analyzed popular vaping behavior and revealed the advantages of vaporizing medical cannabis. The general advantages of vaporizing medical cannabis include portability, concealability, and efficiency, while the medical advantages like promoting tobacco cessation and it’s quick-acting effects.

News

What Is The Entourage Effect?

Along with THC, the cannabis plant produces over 400 different chemical compounds that include dozens of other cannabinoids like CBD and CBN, and hundreds terpenes like pinene, linalool and myrcene. When the compounds are applied together (whether it’s through smoking, vaping or especially transdermal applications), they work to provide unique effects and benefits.

Events

Cannabis and Men's Health: A CED Clinic Live Webinar

In honor of Men's Health Month, tonight's webinar will focus on the unique differences that men may have when consuming cannabis.Join Dr. Caplan this evening to review the latest cannabis studies that relate to men's sexual, mental and physical health. All are welcome to attend and share their experiences, or to simply listen and learn.

Research

Effects of Cannabis for Pain

A recent meta-analysis has found that cannabis is an effective treatment for those dealing with chronic pain. Researchers analyzed studies that compared cannabinoid-based therapies to placebos, concluding that those therapies served as an effective replacement or adjunctive therapy for more common pain relievers, such as opioids.

The Latest

Featured

EO Care, Inc. Statement on Cannabinoid Policy Announcements

EO Data & Methodology: November 2025 Update

EO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data

Gaps in Guidance

CBD & Gastrointestinal Pain

Cannabinoids & Pain Control

Cannabis & Sleeplessness

CB2 as a Regulator of Anxiety & Potential Target for PTSD Drugs

The Pros & Cons of Vaporization

What Is The Entourage Effect?

Cannabis and Men's Health: A CED Clinic Live Webinar

Effects of Cannabis for Pain

EO in Your Inbox